The Colorectal Cancer Alliance and 130 organizations sent a letter to President Joseph R. Biden, key members of his administration, and leading public health officials at state health departments to underscore the importance of prioritizing patients with active cancer and survivors of cancer when administering the lifesaving COVID-19 vaccines
Brand name drugs can be significantly more expensive than generic versions. With the FDA approval of a generic version of a chemotherapy drug to treat breast and colon cancer, patients who had been receiving the brand-name version of Xeloda will be spending less for the same treatment and patients who couldn’t afford the medication can now ask their doctors if the generic version is right for them.
Lee Dranikoff, the new Chair of the Colorectal Cancer Alliance's Board of Directors, has a personal connection to the disease. In 2014, his wife Joanna was diagnosed with stage IV rectal cancer at age 46. She died less than two years later. Dranikoff has served on the Alliance's Board since 2018.
The Colorectal Cancer Alliance is proud to again award funding to leading researchers investigating pivotal colorectal cancer questions to accelerate our vision of a world free of this disease.
A new Colorectal Cancer Alliance marketing campaign, launched in Washington D.C., Philadelphia, Houston, Atlanta and Phoenix, targets populations most at risk and healthcare providers to highlight the importance of screening and the safe options available.
The Colorectal Cancer Alliance, along with a group of other colorectal cancer organizations, applauds the United States Preventive Services Task Force (USPSTF) draft recommendation to lower the screening age for colorectal cancer to 45 years old for average risk individuals.
This year DC-based, national non-profit the Colorectal Cancer Alliance’s Blue Hope Bash goes nationwide welcoming an entire nation for a once-in-a-lifetime opportunity for the community to unite and confront present-day challenges.
The Caregiver Survey Report 2020 highlights the knowledge and support gaps reported by more than 200 caregivers, including needs related to medical decision making, financial support, parenting, mental health, and household and patient transportation issues.
Ally to Ally, an online community where colorectal cancer patients, survivors, and caregivers meet to connect, share, and learn was launched by the Colorectal Cancer Alliance. Peer support is a cornerstone of the Alliance, and Ally to Ally’s advanced features let members easily find the people and information most relevant to them.
The Colorectal Cancer Alliance and TrialJectory share preliminary data resulting from their recent collaboration to democratize access to advanced cancer treatments and critical research.
The launch of the Alliance's Integrative Health and Wellness program comes after a survey conducted earlier this year showed that patients, survivors, and caregivers receive inconsistent information about integrative health and wellness, if they receive any information at all. The survey also showed that most individuals who have participated in these activities have noticed a positive difference in their quality of life.
The ugly truth: the process of a traditional colonoscopy is pretty darn unappealing. The prep (yuk!) and idea of a scope being inserted you-know-where doesn’t set people running to the doctor – in fact, it makes some people run the other direction. But we know colon cancer screenings are essential to nipping colon cancer in the bud (or butt…) before it starts. Could CT (virtual) colonoscopy be the answer to tearing down this potential barrier to screening?
The recommendations for use of consistent language will significantly improve patient awareness and understanding of potentially life-saving testing options available for both new cancer diagnoses and progression or recurrence of disease.
COVID-19 has produced far-reaching and significant health impacts, including a drastic reduction in all cancer screenings. In response, national nonprofit Colorectal Cancer Alliance and the National Colorectal Cancer Roundtable—an organization founded by the American Cancer Society and the Centers for Disease Control and Prevention—convened a panel of prevention and screening experts to offer a united response and propose national guidance on improving colorectal cancer screening rates during the COVID-19 era.
The Colorectal Cancer Alliance (Alliance) launches its Personalized Biomarker Patient Education Campaign to empower patients and caregivers with information about how precision treatment planning in colorectal cancer through biomarker testing can help improve survival
The Never Too Young Survey Report shares the self-reported medical, psychosocial, and quality of life experiences of this often-overlooked population to better understand their challenges and needs.
In January 2019, Brooks Bell was diagnosed with stage-III colon cancer at age 38. She underwent six months of surgeries and chemotherapy. During that time, she learned of the shocking rise of colorectal cancer in young people, which inspired her to share her story, establish an awareness campaign, and start an initiative and event to encourage colorectal cancer screening.
The Colorectal Cancer Alliance and the National Colorectal Cancer Roundtable convened a panel of prevention and screening experts to offer a united response and propose national guidance on improving colorectal cancer screening rates during the COVID-19 era.
The March Forth Leadership Council brings together expertise and resources from a variety of stakeholders to improve colorectal cancer screening in targeted communities.